Literature DB >> 23768734

Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease.

Ingunn Skjørten1, Janne Mykland Hilde, Morten Nissen Melsom, Viggo Hansteen, Kjetil Steine, Sjur Humerfelt.   

Abstract

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is a common cause of pre-capillary pulmonary hypertension (PH). This complication may be overlooked in patients with COPD, as symptoms frequently are attributed to ventilatory limitation. Predictors of PH may identify patients with increased risk of morbidity and mortality.
OBJECTIVE: The aims of this COPD study were to (i) evaluate the relationship between mean pulmonary artery pressure (mPAP) and PaO2, (ii) identify significant predictors of mPAP and PaO2 and (iii) use PaO2 as a marker of PH.
METHODS: Altogether 95 COPD patients with mild to very severe airway obstruction and without left ventricular (LV) dysfunction were included. Pulmonary function tests, right heart catheterizations and exercise tests with blood gases were performed.
RESULTS: Multivariate regression analyses showed that only PaO2 was a significant predictor of mPAP. FEV1 and mPAP were significant predictors of PaO2 both at rest and at peak exercise. PaO2 at peak exercise was better to identify pulmonary hypertension than PaO2 at rest. By combining PaO2 at rest and peak exercise, it was possible to predict PH with a detection rate of 76% and a false-positive rate of 24%.
CONCLUSION: In an outpatient COPD population where LV disease was thoroughly excluded, we observed that only PaO2 was a significant predictor of mPAP. PaO2 at rest and peak exercise below 9.5 kPa (71 mmHg) and 8.5 kPa (64 mmHg), respectively, indicates the need for further evaluation of coexisting PH.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Hypoxia; PaO(2); Pulmonary hypertension

Mesh:

Substances:

Year:  2013        PMID: 23768734     DOI: 10.1016/j.rmed.2013.03.021

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

1.  Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema.

Authors:  Aslıhan Gürün Kaya; Berna Akıncı Özyürek; Tuğçe Şahin Özdemirel; Miraç Öz; Yurdanur Erdoğan
Journal:  Med Princ Pract       Date:  2020-08-25       Impact factor: 1.927

2.  The T helper type 17/regulatory T cell imbalance was associated with Ras-GTPase overexpression in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease.

Authors:  Rong Zhu; Xiaochen Xie; Nana Wang; Liang Chen; Yongqing Hong
Journal:  Immunology       Date:  2019-06-24       Impact factor: 7.397

3.  The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis.

Authors:  Limin Zhang; Yujia Liu; Shuai Zhao; Zhen Wang; Miaomiao Zhang; Su Zhang; Xinzhuo Wang; Shuang Zhang; Wenyan Zhang; Liying Hao; Guangyu Jiao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-10

4.  Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

Authors:  Karina Portillo; Yolanda Torralba; Isabel Blanco; Felip Burgos; Roberto Rodriguez-Roisin; Jose Rios; Josep Roca; Joan A Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-14

Review 5.  The role of pulmonary arterial stiffness in COPD.

Authors:  Jonathan R Weir-McCall; Allan D Struthers; Brian J Lipworth; J Graeme Houston
Journal:  Respir Med       Date:  2015-06-12       Impact factor: 3.415

6.  Pulmonary Arterial Pressure Response During Exercise in COPD: A Correlation with C-Reactive Protein (hsCRP).

Authors:  Janos Varga; Attila Palinkas; Imre Lajko; Ildikó Horváth; Krisztina Boda; Attila Somfay
Journal:  Open Respir Med J       Date:  2016-01-29

7.  Mechanisms of ECG signs in chronic obstructive pulmonary disease.

Authors:  Marte Strømsnes Larssen; Kjetil Steine; Janne Mykland Hilde; Ingunn Skjørten; Christian Hodnesdal; Knut Liestøl; Knut Gjesdal
Journal:  Open Heart       Date:  2017-03-22

8.  Exercise capacity in COPD patients with exercise-induced pulmonary hypertension.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-31

Review 9.  Pulmonary hypertension and right heart dysfunction in chronic lung disease.

Authors:  Amirmasoud Zangiabadi; Carmine G De Pasquale; Dimitar Sajkov
Journal:  Biomed Res Int       Date:  2014-07-24       Impact factor: 3.411

10.  Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD.

Authors:  Ingunn Skjørten; Janne Mykland Hilde; Morten Nissen Melsom; Jonny Hisdal; Viggo Hansteen; Kjetil Steine; Sjur Humerfelt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.